Search Login Register

Dwarfism Summary

Description: A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.

Also Known As: Nanism

Networked: 1032 relevant articles (14 outcomes, 38 trials/studies) for this Disease

Key Drugs and Agents for Dwarfism

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Hormones : 2 outcomes 2 studies in 55 results : IBA
  2. Proteins (Proteins, Gene) : 2 outcomes 1 study in 19 results : IBA
  3. Insulin-Like Growth Factor I (IGF-1) : 1 outcome 5 studies in 50 results : IBA
  4. Human Growth Hormone (Saizen) : 1 outcome 4 studies in 41 results : FDA 15 Generic
  5. Transfer RNA (tRNA) : 1 outcome 1 study in 2 results : IBA
  6. Somatotropin Receptors (Growth Hormone Receptor) : 1 outcome in 12 results : IBA
  7. Thyroxine (Levothyroxine) : 1 outcome in 4 results : FDA 13 Generic
  8. Gibberellins : 1 outcome in 4 results : IBA
  9. Cellulose : 1 outcome in 2 results : IBA
  10. Small Interfering RNA (siRNA) : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Dwarfism

  1. Lysosomal Storage Diseases (Lysosomal Storage Disease)
  2. Neoplasms (Cancer)
  3. Hypoglycemia (Reactive Hypoglycemia)
  4. Cataract (Cataracts)
  5. Nervous System Diseases (Neurological Disorders)
Show All >>

Key Therapies for Dwarfism

Efficacy Chart >>
  1. Hip Replacement Arthroplasty (Total Hip Replacement) : 1 outcome in 1 result
  2. Transplants (Transplant) : 2 studies in 4 results
  3. Drug Therapy (Chemotherapy) : 1 study in 1 result
  4. Arthroplasty : 8 results
  5. Injections : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.